Welcome to our dedicated page for Scilex Holding Co SEC filings (Ticker: SCLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Scilex Holding Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Scilex Holding Co's regulatory disclosures and financial reporting.
Scilex Holding Company reported continued operating and financial pressure for the quarter and six months ended June 30, 2026. Net revenue was $7.6 million for the quarter and $16.3 million year‑to‑date, while operating expenses of $37.1 million for the quarter and $77.8 million for six months drove a loss from operations of $61.6 million year‑to‑date.
Total other expense of $99.0 million for the six months was dominated by unrealized and realized losses on the Datavault equity method investment, losses on digital assets, and fair‑value changes in debt and derivative instruments, resulting in a six‑month net loss attributable to common stockholders of $158.0 million. The balance sheet shows $253.6 million in total assets against $564.1 million in total liabilities and a stockholders’ deficit of $310.5 million, including an accumulated deficit of $1.08 billion. Cash and cash equivalents were only $0.6 million and working capital was negative by about $476 million, leading management to state that substantial doubt exists about Scilex’s ability to continue as a going concern absent additional financing and improved product sales.
Scilex Holding Company entered into a Promissory Note (Revolving Line of Credit) with Vivasor, Inc. effective August 8, 2026, establishing an uncommitted revolving credit facility with a maximum aggregate principal amount of up to $20,000,000. The facility has a stated maturity of 120 months from the effective date, with interest on borrowings at 5% per annum, accruing on each funded drawdown until repayment.
Vivasor may request multiple drawdowns before maturity, and repaid amounts may be reborrowed, but Scilex has no obligation to fund any request and may decide in its sole discretion. Any funded drawdown may be provided in cash, freely tradable Scilex securities, shares of Datavault AI, Inc. common stock currently held by Scilex or its subsidiaries, or a combination of these. All outstanding principal and accrued interest are due at maturity, and Vivasor may prepay at any time without penalty. The note becomes immediately due upon certain customary events of default. Dr. Henry Ji, Ph.D., Scilex’s Chief Executive Officer, President and Chairperson, also serves as Vivasor’s Chief Executive Officer, and the arrangement was approved by Scilex’s Board of Directors and Audit Committee.
Scilex Holding Company entered into a stock repurchase agreement with Vivasor Holding Company on July 18, 2026, under which Scilex agreed to sell 6,101,468 shares of Vivasor Series A-1 Preferred Stock and 355,919 shares of Vivasor Series A-2 Preferred Stock that Scilex had acquired in January 2026.
Vivasor will purchase these shares for an aggregate purchase price of $11,999,762.28, payable in cash by wire transfer, by assignment of Datavault AI, Inc. common stock held by a Vivasor subsidiary, or a combination of both. The price will be paid in five tranches between July 18, 2026 and June 30, 2027. The agreement includes customary representations, warranties, covenants and indemnification provisions. Scilex’s Chief Executive Officer, President and Chairperson, Dr. Henry Ji, Ph.D., also serves as Chief Executive Officer of Vivasor.
SCLX Stock Acquisition JV LLC, a Texas entity, reports beneficial ownership of 30,029,378 Scilex Holding Company securities, representing 11.4% of the common stock class when including 14,018 warrant shares that are exercisable within 60 days.
The holdings include 958,263 common shares and 29,057,097 shares of Series A Preferred Stock, which together with the warrants provide aggregate voting power of 19.3%, including 848,106 votes from the preferred stock. The filing notes Scilex’s 1‑for‑35 reverse stock split on April 15, 2025, and discloses that on July 3, 2026, the reporting person agreed to transfer 500,000 Scilex common shares to Quantum Scan Holdings, Inc. in exchange for Q Scan common stock under a letter agreement.
SCLX Stock Acquisition JV LLC, a major holder of Scilex Holding Co, restructured its position by transferring 500,000 shares of common stock to Quantum Scan Holdings, Inc. in exchange for Q Scan common stock under a letter agreement. The transfer price will be based on the Scilex closing price on the Nasdaq Capital Market on the last trading day immediately before the transfer. After this transaction, the reporting entity holds 958,263 Scilex shares, and the reported holdings already reflect a 1-for-35 reverse stock split effective April 15, 2025.
Scilex Holding Company entered into a binding term sheet with iHolding Group LLP for a proposed $100,000,000 equity investment in newly issued common shares. The parties expect a purchase price of $15.00 per share, which would represent approximately 6,666,667 shares if completed.
The proposal is subject to customary due diligence, negotiation and execution of definitive agreements, board and stockholder approvals, regulatory clearances and other closing conditions, and it may be modified or terminated. Scilex currently expects that, if structured as a private placement, the issuance would rely on exemptions under Section 4(a)(2) and Rule 506 of Regulation D. A press release describing the term sheet and intended use of proceeds for strategic growth, product development, acquisitions, working capital and other corporate purposes was furnished as an exhibit.
Scilex Holding Company has signed a binding term sheet to buy 837 Bitcoin from Datavault AI Inc. for $50 million. The assets are currently held in a Biconomy digital wallet, and the deal is structured as a proposed purchase rather than a completed acquisition.
Scilex plans an initial payment of $30 million, with the remaining $20 million in quarterly installments from the fourth quarter of 2026 through December 31, 2028. The company may pay in cash, common stock, publicly traded securities of its subsidiaries, or a mix, at its discretion. The transaction depends on negotiating a definitive agreement, securing approvals, and satisfying customary closing conditions, and may ultimately not be completed.
Scilex Holding Company reported voting results from its 2026 annual stockholder meeting. All Series A preferred shares, totaling 29,057,097, and 5,389,081 common shares were represented, based on 8,491,267 common shares outstanding as of April 28, 2026.
Stockholders elected Dorman Followwill as a Class I director, ratified BPM LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved an amendment to the 2022 Equity Incentive Plan. The plan’s share reserve was increased by 1,300,000 shares to 2,765,789 shares, including the same total available for incentive stock options.
Scilex Holding Company filed a shelf registration to register up to 2,083,067 shares of Common Stock issuable by the company, up to 6,581,004 resale shares to be offered by selling securityholders and up to 490,617 warrants for resale, all to be offered from time to time.
The prospectus states the Company will receive proceeds only from cash exercises of warrants and expects to receive up to $144.9 million assuming full cash exercise of the Warrants and conversion described; resale proceeds will go to the selling securityholders. The filing discloses the Company may use cash proceeds in part to purchase and stake cryptocurrencies as a treasury strategy.